"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 31 | 31 |
| 2004 | 0 | 61 | 61 |
| 2005 | 1 | 60 | 61 |
| 2006 | 0 | 65 | 65 |
| 2007 | 0 | 92 | 92 |
| 2008 | 0 | 77 | 77 |
| 2009 | 1 | 95 | 96 |
| 2010 | 1 | 106 | 107 |
| 2011 | 0 | 88 | 88 |
| 2012 | 1 | 115 | 116 |
| 2013 | 0 | 111 | 111 |
| 2014 | 1 | 130 | 131 |
| 2015 | 0 | 125 | 125 |
| 2016 | 0 | 122 | 122 |
| 2017 | 0 | 105 | 105 |
| 2018 | 0 | 102 | 102 |
| 2019 | 1 | 97 | 98 |
| 2020 | 0 | 83 | 83 |
| 2021 | 0 | 81 | 81 |
| 2022 | 0 | 26 | 26 |
| 2023 | 0 | 32 | 32 |
| 2024 | 0 | 73 | 73 |
| 2025 | 0 | 72 | 72 |
| 2026 | 0 | 47 | 47 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent. Sci Adv. 2026 Sep 11; 12(37):eadz6815.
-
Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy-Resistant Breast Cancer. Mol Cancer Res. 2026 Sep 02; 24(9):784-800.
-
Galanin impairs tumor immunity in glioblastoma by promoting infiltration and ferroptosis resistance of myeloid-derived suppressor cells. Nat Cancer. 2026 Sep; 7(9):1387-1405.
-
Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers. Gynecol Oncol. 2026 Sep; 212:134-144.
-
Mannose supports lung cancer metabolism during glycolytic limitation. EMBO Rep. 2026 Sep; 27(18):5365-5381.
-
Stabilized phospholipid-topotecan prodrug particles increase vascular permeability and ultrasound-enhanced neuroblastoma delivery. Int J Pharm. 2026 Oct 05; 703:127283.
-
Microenvironmental arginine restriction sensitizes pancreatic cancers to polyunsaturated fatty acids by suppression of lipid synthesis. Elife. 2026 Aug 05; 14.
-
Targeting Menin in T-lineage Acute Lymphoblastic Leukemia. Mol Cancer Ther. 2026 Aug 04; 25(8):1294-1304.
-
Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy. Sci Adv. 2026 Jul 24; 12(30):eadz1388.
-
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia. Clin Cancer Res. 2026 Jul 17; 32(14):3018-3030.